BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29736244)

  • 1. Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.
    Del Frari L; Léauté-Labrèze C; Guibaud L; Barbarot S; Lacour JP; Chaumont C; Delarue A; Voisard JJ; Brunner V
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00399. PubMed ID: 29736244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma.
    Takechi T; Kumokawa T; Kato R; Higuchi T; Kaneko T; Ieiri I
    J Clin Pharmacol; 2018 Oct; 58(10):1361-1370. PubMed ID: 29746707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of oral propranolol in infantile hemangioma.
    Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
    N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
    Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
    Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.
    Gastine S; Lehrnbecher T; Müller C; Farowski F; Bader P; Ullmann-Moskovits J; Cornely OA; Groll AH; Hempel G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
    MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
    J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
    Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
    Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
    Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
    Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
    Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
    Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas.
    Huang AH; Mannschreck D; Aggarwal P; Mahon M; Cohen BA
    Pediatr Dermatol; 2020 Nov; 37(6):1057-1062. PubMed ID: 32869385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol concentrations after oral administration in term and preterm neonates.
    Filippi L; Cavallaro G; Fiorini P; Malvagia S; Della Bona ML; Giocaliere E; Bagnoli P; Dal Monte M; Mosca F; Donzelli G; la Marca G
    J Matern Fetal Neonatal Med; 2013 May; 26(8):833-40. PubMed ID: 23205867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep coma in a child treated with propranolol for infantile hemangioma.
    Bakalli I; Kola E; Lluka R; Celaj E; Sala D; Gjeta I; Sallabanda S; Klironomi D
    BMC Pediatr; 2019 Jul; 19(1):216. PubMed ID: 31266444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
    Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
    Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
    Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
    Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.